ABOUT THE EXPERT

Christopher Flowers,

MD, MS

Chair, Department of Lymphoma/Myeloma
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX

Christopher Flowers, MD, MS, joined The University of Texas MD Anderson Cancer Center in Houston as chair of the Department of Lymphoma/Myeloma in August 2019. Prior to his arrival, he was professor of hematology and oncology with a joint appointment in Biomedical Informatics at Emory University School of Medicine in Atlanta, GA. He served as director of the Emory Healthcare – Lymphoma Program at Winship Cancer Institute and as scientific director of Winship Research Informatics, which works in collaboration with Winship Cancer Institute.

Dr Flowers earned his medical degree from Stanford University School of Medicine, where he also completed a master of science degree in medical informatics to gain expertise in the development of information systems to improve clinical research. He completed his internship and residency in internal medicine at the University of Washington in Seattle, where he continued his research training as a fellow in the Robert Wood Johnson Clinical Scholars Program and earned a second master’s degree in pharmaceutical outcomes research and policy. During this time, he also completed his fellowship in medical oncology at the Fred Hutchinson Cancer Research Center.

An internationally recognized expert in lymphoma clinical care, epidemiology, and outcomes research, Dr Flowers is an innovator who has a passion for facilitating new drug development. He is an active clinician who conducts clinical research involving cancer outcomes, cancer informatics, and phase 1/2 trials focusing on the clinical development of novel therapeutics for B-cell lymphomas. His broader research interests include patient-oriented research in lymphoma and computer microsimulation models aimed at developing strategies to individualize the care of patients with cancer, improve systems of care, and accelerate new drug development. His work has resulted in more than 300 peer-reviewed publications. He has received peer-reviewed funding from foundations and from the National Institutes of Health, including leading 2 U01 awards and 2 multi-institutional team science grants.

Dr Flowers has served for international professional societies in many capacities. Has was elected to membership in the American Society for Clinical Investigation and was named a fellow of the American Society of Clinical Oncology.

CONTRIBUTING ARTICLES